Petitte Trisha, Nichols Allison, Narsavage Georgia
School of Nursing, West Virginia University, Morgantown, West Virginia, USA.
Extension Service, West Virginia University, Morgantown, West Virginia, USA.
EC Pulmonol Respir Med. 2019 Sep;8(9):600-606. Epub 2019 Aug 16.
West Virginia (WV) residents have often rejected participation in community-based cancer research studies. Nationally, 49% of eligible patients participate in clinical trials but less than 10% of patients in WV participate.
To understand issues related to recruitment and retention of patients for cancer research in Appalachian WV.
Data were obtained from 3 focus groups including: (1) 9 patients who participated in clinical cancer trials, (2) 8 cancer research nurse coordinators, and (3) 10 physicians involved in cancer research. Groups were audio-taped and transcriptions were analyzed using MAXQDA and results were verified by two co-investigators.
Most enablers and barriers identified were cultural as indicated by 72% of patients; 68% nurse coordinators; and 55% physicians. Patients identified personal emotional strength as an enabler, and negative health behaviors and fears as barriers. Enablers that nurses identified were positive patient characteristics and barriers included fear of trials, randomization, and death. Physicians identified enablers as a patient's understanding of the clinical trial and motivation to help others and the inverse of these two enablers as barriers.
A foundation for improving recruitment and retention of participants in cancer research in Appalachia was identified. The next step will involve cancer community organizations and patients in developing a plan to enhance enablers and overcome barriers to patient recruitment in cancer studies.
Cultural influences must be considered when recruiting for clinical trials. Community organizations educating the public about cancer research may be the key to enhancing patient enrollment.
西弗吉尼亚州(WV)居民常常拒绝参与基于社区的癌症研究。在全国范围内,49%符合条件的患者参与临床试验,但WV参与的患者不到10%。
了解西弗吉尼亚州阿巴拉契亚地区癌症研究中患者招募和留存相关的问题。
数据来自3个焦点小组,包括:(1)9名参与临床癌症试验的患者,(2)8名癌症研究护士协调员,以及(3)10名参与癌症研究的医生。各小组进行了录音,并使用MAXQDA对转录内容进行分析,结果由两名共同研究者核实。
如72%的患者、68%的护士协调员和55%的医生所指出的,大多数已确定的促进因素和障碍是文化方面的。患者将个人情感力量视为促进因素,将负面健康行为和恐惧视为障碍。护士确定的促进因素是患者的积极特征,障碍包括对试验、随机分组和死亡的恐惧。医生将患者对临床试验的理解和帮助他人的动机视为促进因素,而将这两个促进因素的反面视为障碍。
确定了改善阿巴拉契亚地区癌症研究参与者招募和留存的基础。下一步将让癌症社区组织和患者参与制定一项计划,以增强促进因素并克服癌症研究中患者招募的障碍。
招募临床试验参与者时必须考虑文化影响。社区组织向公众宣传癌症研究可能是提高患者入组率的关键。